Golimumab is a human monoclonal antibody that also targets the TNF and it is currently used to treat moderate to severe active psoriatic arthritis, rheumatoid arthritis, and ankylosing spondylitis [11]. The gene discussed is TNF; the disease is psoriatic arthritis.